OrganAID Holdings
PrivateLast Round
Grant
Oct 17, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OrganAID Holdings is a biotechnology company that develops a drug-testing platform using brain organoids derived from patient cells and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrganAID Holdings Comparables
Compare OrganAID Holdings with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProxyBio | 84% | |
| Vivodyne | 84% | |
| CELLphenomics GmbH | 79% |
OrganAID Holdings Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 17, 2025 |
Key People
Founding team and executive leadership
OrganAID Holdings Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pompeu Fabra University | Grant |
| University of Barcelona | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 17, 2025
Received grant funding from "la Caixa" Foundation and universities.
OrganAID Holdings Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OrganAID Holdings's valuation, stock price, and market status.
Is OrganAID Holdings a public or private company?
OrganAID Holdings is a private company.
What is the current stock price of OrganAID Holdings?
OrganAID Holdings is a private company, so its shares have no public market price. Caplight tracks OrganAID Holdings's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OrganAID Holdings worth (valuation)?
Valuation information for OrganAID Holdings is not publicly available.
Can I buy OrganAID Holdings stock?
OrganAID Holdings shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OrganAID Holdings's last funding round?
OrganAID Holdings's most recent funding round was Grant on October 17, 2025.
Who are the main investors in OrganAID Holdings?
Key investors in OrganAID Holdings include Pompeu Fabra University, University of Barcelona.
Will OrganAID Holdings IPO soon?
No public IPO plans have been announced for OrganAID Holdings.
How can I track OrganAID Holdings secondary market activity?
Caplight tracks bids, offers, and trades in OrganAID Holdings's shares on secondary markets.